XenoPort, Inc., incorporated in May, 1999, is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates, which utilizes the body's natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs.
Last Friday, XenoPort, Inc. (NASDAQ:XNPT) started to gain on the market. The stock soared 2.42% on its price to close at $6.34 per share and its volume exceeded 525 thousand shares traded.read more